Dataset from Zenodo · Murugan, Vel
Data from: Serosurvey of SARS-COV-2 at a large public university
- License
- CC0 1.0commercial use allowedLicense text
- This license allows commercial use. Usually you must credit the author; read the license for the exact terms.
- Formats
- XLSX, MD
- Size
- 154 kB
- Updated
- Jul 13, 2023
Description
Objective : This study investigated the seroprevalence of SARS-CoV-2 antibodies among adults over 18 years. Design : Prospective cohort study. Settings : a population-based study among the big university community. Participants : This study took volunteers over five days and recruited adult 1064 participants. Primary outcome measures : We conducted a seroprevalence in our community with SARS-CoV-2-specific antibodies due to previous exposure to SARS-CoV-2 and/or vaccination. Results : The seroprevalence of the anti-receptor binding domain (RBD) antibody was 90% by a lateral flow assay and 88% by a semi-quantitative chemiluminescent immunoassay. The seroprevalence for anti-nucleocapsid (NC) was 20%. In addition, individuals with previous natural COVID infection plus vaccination had higher anti-RBD antibody levels compared to those who had vaccination only or infection only. Individuals who had a breakthrough infection had the highest anti-RBD antibody levels. Conclusion : Accurate estimates of the cumulative incidence of SARS-CoV-2 infection can inform the development of university risk mitigation protocols such as encouraging booster shots, extending mask mandates, or reverting to…
Description from Zenodo, shortened.
Files (2)
DataHunter does not store or host these files: every link leads to the original source. Check the license there before using the data.